HLAG Antikörper (APC)
-
- Target Alle HLAG Antikörper anzeigen
- HLAG (HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser HLAG Antikörper ist konjugiert mit APC
-
Applikation
- ELISA, Flow Cytometry (FACS), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunoprecipitation (IP), Immunocytochemistry (ICC)
- Spezifität
- Reacts with the native form of human HLA-G1 on the cell surface
- Kreuzreaktivität
- Maus
- Kreuzreaktivität (Details)
- Also reacts with the soluble HLA-G5 isoform in its beta2-microglobulin associated form. Does not cross-react with mouse protein.
- Aufreinigung
- Purified (liquid chromatography)
- Immunogen
- Recombinant human HLA-G refolded with beta2-microglobulin and peptide.
- Klon
- MEM-G-9
- Isotyp
- IgG1
- Top Product
- Discover our top product HLAG Primärantikörper
-
-
- Applikationshinweise
-
Working dilution: Optimal dilutions should be determined by the end user.
The following are guidelines only:
- FC: 1:100 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS, BSA 0.2 % (w/v), Sodium azide 15 mM
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Informationen zur Lagerung
- Store in the dark at 2-8°C. Do not freeze. Avoid prolonged exposure to light.
-
- Target
- HLAG (HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG))
- Andere Bezeichnung
- HLA-G (HLAG Produkte)
- Synonyme
- MHC-G antikoerper, B-F antikoerper, B-F-S04 antikoerper, B-F-S05 antikoerper, B-F-S06 antikoerper, B-F-S07 antikoerper, B-FI antikoerper, B-FIV antikoerper, BF2 antikoerper, BFa2 antikoerper, BFw-03 antikoerper, BFw-05 antikoerper, BFz-01 antikoerper, major histocompatibility complex, class I, G antikoerper, MHC BF1 class I antikoerper, HLA-G antikoerper, BF1 antikoerper
- Gen-ID
- 3135
- Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
-